{"id":313075,"date":"2026-10-16T11:18:16","date_gmt":"2026-10-16T05:48:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=313075"},"modified":"2026-10-16T11:18:16","modified_gmt":"2026-10-16T05:48:16","slug":"pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/","title":{"rendered":"3 Pathology Network, Group Holding Company and FMCG Major Stocks With a Strong Future Roadmap: Suraksha Diagnostic, Godrej Industries and ITC"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Suraksha Diagnostic Rs 307.65, P\/E 46.05. Godrej Industries Rs 1,030.50, P\/E 15.29. ITC Rs 263.90, P\/E 15.77. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Pathology network, group holding company and FMCG major stocks with the clearest long-term roadmaps today include Suraksha Diagnostic in diagnostic and pathology testing through a network of labs and collection centres, Godrej Industries in chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm and ITC in cigarettes, packaged foods, personal care, paperboards, hotels and agri products. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 18.5% at Godrej Industries and 4.4% at ITC. P\/E stands at 46.05 for Suraksha Diagnostic (industry 62.79), 15.29 for Godrej Industries (industry 36.60) and 15.77 for ITC (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Pathology network, group holding company and FMCG major stocks give investors exposure to health tests, group businesses and consumer goods used every day. Volumes, lab additions and margins decide how much of that demand turns into profit.<\/p>\n<p>This list covers three pathology network, group holding company and FMCG major stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, Godrej Industries for chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm and ITC for cigarettes, packaged foods, personal care, paperboards, hotels and agri products. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#What_Are_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks\" title=\"What Are Pathology Network, Group Holding Company and FMCG Major Stocks?\">What Are Pathology Network, Group Holding Company and FMCG Major Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_at_a_Glance\" title=\"Pathology Network, Group Holding Company and FMCG Major Stocks at a Glance\">Pathology Network, Group Holding Company and FMCG Major Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Why_Do_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Pathology Network, Group Holding Company and FMCG Major Stocks Have a Strong Roadmap in India?\">Why Do Pathology Network, Group Holding Company and FMCG Major Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Suraksha_Diagnostic_Diagnostic_Labs_Drive_the_Pipeline\" title=\"Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline\">Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Godrej_Industries_Chemicals_and_Group_Holdings_Build_the_Next_Leg\" title=\"Godrej Industries: Chemicals and Group Holdings Build the Next Leg\">Godrej Industries: Chemicals and Group Holdings Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#ITC_Several_Businesses_Anchor_the_Roadmap\" title=\"ITC: Several Businesses Anchor the Roadmap\">ITC: Several Businesses Anchor the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Best_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_in_India_Suraksha_Diagnostic_vs_Godrej_Industries_vs_ITC_on_Key_Financials\" title=\"Best Pathology Network, Group Holding Company and FMCG Major Stocks in India: Suraksha Diagnostic vs Godrej Industries vs ITC on Key Financials\">Best Pathology Network, Group Holding Company and FMCG Major Stocks in India: Suraksha Diagnostic vs Godrej Industries vs ITC on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#How_to_Evaluate_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Pathology Network, Group Holding Company and FMCG Major Stocks to Buy Before You Invest\">How to Evaluate Pathology Network, Group Holding Company and FMCG Major Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Risks_to_Consider_Before_Investing_in_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks\" title=\"Risks to Consider Before Investing in Pathology Network, Group Holding Company and FMCG Major Stocks\">Risks to Consider Before Investing in Pathology Network, Group Holding Company and FMCG Major Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#FAQs_on_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks\" title=\"FAQs on Pathology Network, Group Holding Company and FMCG Major Stocks\">FAQs on Pathology Network, Group Holding Company and FMCG Major Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Which_are_the_best_pathology_network_group_holding_company_and_FMCG_major_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best pathology network, group holding company and FMCG major stocks in India with a strong roadmap?\">Which are the best pathology network, group holding company and FMCG major stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Is_Suraksha_Diagnostic_a_good_stock_to_buy_now\" title=\"Is Suraksha Diagnostic a good stock to buy now?\">Is Suraksha Diagnostic a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#What_is_the_PE_ratio_of_Suraksha_Diagnostic_Godrej_Industries_and_ITC\" title=\"What is the P\/E ratio of Suraksha Diagnostic, Godrej Industries and ITC?\">What is the P\/E ratio of Suraksha Diagnostic, Godrej Industries and ITC?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Which_of_these_pathology_network_group_holding_company_and_FMCG_major_stocks_has_the_highest_return_on_equity\" title=\"Which of these pathology network, group holding company and FMCG major stocks has the highest return on equity?\">Which of these pathology network, group holding company and FMCG major stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#What_are_the_risks_of_investing_in_pathology_network_group_holding_company_and_FMCG_major_stocks\" title=\"What are the risks of investing in pathology network, group holding company and FMCG major stocks?\">What are the risks of investing in pathology network, group holding company and FMCG major stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#How_did_Suraksha_Diagnostic_Godrej_Industries_and_ITC_perform_in_Q1_FY27\" title=\"How did Suraksha Diagnostic, Godrej Industries and ITC perform in Q1 FY27?\">How did Suraksha Diagnostic, Godrej Industries and ITC perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#Do_pathology_network_group_holding_company_and_FMCG_major_stocks_pay_dividends\" title=\"Do pathology network, group holding company and FMCG major stocks pay dividends?\">Do pathology network, group holding company and FMCG major stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/pathology-network-group-holding-company-and-fmcg-major-stocks-roadmap-vantage-list\/#How_can_I_invest_in_pathology_network_group_holding_company_and_FMCG_major_stocks_in_India\" title=\"How can I invest in pathology network, group holding company and FMCG major stocks in India?\">How can I invest in pathology network, group holding company and FMCG major stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks\"><\/span><strong>What Are Pathology Network, Group Holding Company and FMCG Major Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pathology network, group holding company and FMCG major stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_at_a_Glance\"><\/span><strong>Pathology Network, Group Holding Company and FMCG Major Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three pathology network, group holding company and FMCG major stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/suraksha\/suraksha-diagnostic-ltd-share-price-today\">Suraksha Diagnostic<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">307.65<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,614<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.79<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.15%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/godrejind\/godrej-industries-ltd-share-price-today\">Godrej Industries<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,030.50<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33,784<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.29<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.60<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.10%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/itc\/itc-ltd-share-price-today\">ITC<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">263.90<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">318,338<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.77<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28.53%<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Pathology Network, Group Holding Company and FMCG Major Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pathology network, group holding company and FMCG major stocks have a strong roadmap in India because preventive health checks, diversified group earnings and wider consumer brands keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Preventive health:<\/strong> Families test more often and earlier.<\/li>\n<li><strong>Group strength:<\/strong> Chemicals and listed stakes spread earnings across sectors.<\/li>\n<li><strong>Brand spread:<\/strong> Packaged foods and personal care reach more homes.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Suraksha_Diagnostic_Diagnostic_Labs_Drive_the_Pipeline\"><\/span><strong>Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Suraksha Diagnostic&#8217;s roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.<\/p>\n<p>Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.<\/p>\n<p>Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P\/E of 46.05 against an industry P\/E of 62.79, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Godrej_Industries_Chemicals_and_Group_Holdings_Build_the_Next_Leg\"><\/span><strong>Godrej Industries: Chemicals and Group Holdings Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Godrej Industries&#8217; roadmap rests on chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm, with its chemical business and holdings in other group companies widening the earnings base.<\/p>\n<p>Revenue grew from Rs 15,064.67 crore in FY22 to Rs 25,980.60 crore in FY26, a 72.5% rise, and FY26 revenue was 18.5% higher than FY25. FY26 net profit rose 29.8% to Rs 2,411.91 crore. Over four years, net profit rose from Rs 992.43 crore in FY22 to Rs 2,411.91 crore. In Q1 FY27, revenue grew 11.2% to Rs 6,360.30 crore. Operating margin was 26.91% in FY26.<\/p>\n<p>Return on equity is 11.10%. At a P\/E of 15.29 against an industry P\/E of 36.60, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 15.29 against an industry P\/E of 36.60 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"ITC_Several_Businesses_Anchor_the_Roadmap\"><\/span><strong>ITC: Several Businesses Anchor the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>ITC&#8217;s roadmap rests on cigarettes, packaged foods, personal care, paperboards, hotels and agri products, with several businesses supporting steady cash flow.<\/p>\n<p>Revenue grew from Rs 62,504.44 crore in FY22 to Rs 81,294.27 crore in FY26, a 30.1% rise, and FY26 revenue was 4.4% higher than FY25. FY26 net profit rose 4.9% to Rs 21,018.15 crore. Over four years, net profit rose from Rs 15,503.13 crore in FY22 to Rs 21,018.15 crore. In Q1 FY27, revenue grew 26.7% to Rs 30,179.01 crore. Operating margin was 33.18% in FY26.<\/p>\n<p>Debt to equity is 0.03 and return on equity is 28.53%. FY26 operating cash flow was Rs 18,464.31 crore against capital expenditure of Rs 2,182.89 crore. At a P\/E of 15.77 against an industry P\/E of 34.85, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 15.77 against an industry P\/E of 34.85 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_in_India_Suraksha_Diagnostic_vs_Godrej_Industries_vs_ITC_on_Key_Financials\"><\/span><strong>Best Pathology Network, Group Holding Company and FMCG Major Stocks in India: Suraksha Diagnostic vs Godrej Industries vs ITC on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best pathology network, group holding company and FMCG major stocks in India, Suraksha Diagnostic leads on FY26 revenue growth; Godrej Industries leads on FY26 net profit growth and the lowest P\/E; ITC leads on FY26 operating margin and Q1 FY27 revenue growth. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Suraksha Diagnostic<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Godrej Industries<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ITC<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">313.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25,980.60<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">81,294.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.40<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,411.91<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21,018.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.01%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.91%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.18%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.15%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.10%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.29<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.77<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Pathology Network, Group Holding Company and FMCG Major Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen pathology network, group holding company and FMCG major stocks and shortlist pathology network, group holding company and FMCG major stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these pathology network, group holding company and FMCG major stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks\"><\/span><strong>Risks to Consider Before Investing in Pathology Network, Group Holding Company and FMCG Major Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Suraksha Diagnostic, Godrej Industries and ITC live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare, chemicals and consumer stocks cover diagnostics, a diversified group and consumer goods. Suraksha Diagnostic leads on FY26 revenue growth; Godrej Industries leads on FY26 net profit growth and the lowest P\/E; ITC leads on FY26 operating margin and Q1 FY27 revenue growth.<\/p>\n<p>Across pathology network, group holding company and FMCG major stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the pathology network, group holding company and FMCG major stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Pathology_Network_Group_Holding_Company_and_FMCG_Major_Stocks\"><\/span><strong>FAQs on Pathology Network, Group Holding Company and FMCG Major Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_pathology_network_group_holding_company_and_FMCG_major_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best pathology network, group holding company and FMCG major stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic, Godrej Industries and ITC stand out for their roadmaps in diagnostics, a diversified group and consumer goods. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 18.5% at Godrej Industries and 4.4% at ITC, and return on equity ranges from 11.10% to 28.53%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Suraksha_Diagnostic_a_good_stock_to_buy_now\"><\/span><strong>Is Suraksha Diagnostic a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P\/E of 46.05 against an industry P\/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Suraksha_Diagnostic_Godrej_Industries_and_ITC\"><\/span><strong>What is the P\/E ratio of Suraksha Diagnostic, Godrej Industries and ITC?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 15.29 for Godrej Industries (industry 36.60) and 15.77 for ITC (industry 34.85). All of them trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_pathology_network_group_holding_company_and_FMCG_major_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these pathology network, group holding company and FMCG major stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ITC has the highest return on equity at 28.53%, followed by Suraksha Diagnostic at 13.15% and Godrej Industries at 11.10%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_pathology_network_group_holding_company_and_FMCG_major_stocks\"><\/span><strong>What are the risks of investing in pathology network, group holding company and FMCG major stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Suraksha_Diagnostic_Godrej_Industries_and_ITC_perform_in_Q1_FY27\"><\/span><strong>How did Suraksha Diagnostic, Godrej Industries and ITC perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Godrej Industries reported revenue of Rs 6,360.30 crore, up 11.2% year on year. ITC reported revenue of Rs 30,179.01 crore, up 26.7% year on year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_pathology_network_group_holding_company_and_FMCG_major_stocks_pay_dividends\"><\/span><strong>Do pathology network, group holding company and FMCG major stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic pays dividends. The dividend yield is 0.02% for Suraksha Diagnostic, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_pathology_network_group_holding_company_and_FMCG_major_stocks_in_India\"><\/span><strong>How can I invest in pathology network, group holding company and FMCG major stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy pathology network, group holding company and FMCG major stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best pathology network, group holding company and FMCG major stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic, Godrej Industries and ITC stand out for their roadmaps in diagnostics, a diversified group and consumer goods. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 18.5% at Godrej Industries and 4.4% at ITC, and return on equity ranges from 11.10% to 28.53%.\"}},{\"@type\":\"Question\",\"name\":\"Is Suraksha Diagnostic a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P\/E of 46.05 against an industry P\/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Suraksha Diagnostic, Godrej Industries and ITC?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 15.29 for Godrej Industries (industry 36.60) and 15.77 for ITC (industry 34.85). All of them trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these pathology network, group holding company and FMCG major stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ITC has the highest return on equity at 28.53%, followed by Suraksha Diagnostic at 13.15% and Godrej Industries at 11.10%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in pathology network, group holding company and FMCG major stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.\"}},{\"@type\":\"Question\",\"name\":\"How did Suraksha Diagnostic, Godrej Industries and ITC perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Godrej Industries reported revenue of Rs 6,360.30 crore, up 11.2% year on year. ITC reported revenue of Rs 30,179.01 crore, up 26.7% year on year.\"}},{\"@type\":\"Question\",\"name\":\"Do pathology network, group holding company and FMCG major stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic pays dividends. The dividend yield is 0.02% for Suraksha Diagnostic, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in pathology network, group holding company and FMCG major stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy pathology network, group holding company and FMCG major stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Suraksha Diagnostic, Godrej Industries and ITC compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":35,"featured_media":313074,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[7186,12788,12789,5358,12787,11131],"class_list":["post-313075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-godrej-industries","tag-group-holding-company-and-fmcg-major-stocks","tag-group-holding-company-and-fmcg-major-stocks-to-buy","tag-itc","tag-pathology-network","tag-suraksha-diagnostic"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["313074"],"rank_math_title":["pathology, group holding and FMCG major stocks"],"rank_math_description":["Pathology network, group holding company and FMCG major stocks with a strong roadmap compared on growth, margins, valuation and risks."],"rank_math_focus_keyword":["pathology network, group holding company and FMCG major stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-pathology-network-group-holding-company-and-fmcg-major-stocks-with-a-strong.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/313075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=313075"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/313075\/revisions"}],"predecessor-version":[{"id":313076,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/313075\/revisions\/313076"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/313074"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=313075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=313075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=313075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}